Annual Working Capital
$48.89 M
-$116.48 M-70.44%
31 December 2023
Summary:
Standard BioTools annual working capital is currently $48.89 million, with the most recent change of -$116.48 million (-70.44%) on 31 December 2023. During the last 3 years, it has fallen by -$14.53 million (-22.91%). LAB annual working capital is now -70.44% below its all-time high of $165.37 million, reached on 31 December 2022.LAB Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$332.99 M
-$23.23 M-6.52%
30 September 2024
Summary:
Standard BioTools quarterly working capital is currently $332.99 million, with the most recent change of -$23.23 million (-6.52%) on 30 September 2024. Over the past year, it has increased by +$214.05 million (+179.96%). LAB quarterly working capital is now -21.83% below its all-time high of $426.01 million, reached on 31 March 2024.LAB Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LAB Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -70.4% | +180.0% |
| 3 y3 years | -22.9% | +1172.2% |
| 5 y5 years | -45.4% | +426.3% |
LAB Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -70.4% | +117.3% | -21.8% | +1380.1% |
| 5 y | 5 years | -70.4% | +117.3% | -21.8% | +1380.1% |
| alltime | all time | -70.4% | +1963.7% | -21.8% | >+9999.0% |
Standard BioTools Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $332.99 M(-6.5%) |
| June 2024 | - | $356.22 M(-16.4%) |
| Mar 2024 | - | $426.01 M(+771.4%) |
| Dec 2023 | $48.89 M(-70.4%) | $48.89 M(-58.9%) |
| Sept 2023 | - | $118.94 M(-12.7%) |
| June 2023 | - | $136.23 M(-9.9%) |
| Mar 2023 | - | $151.14 M(-8.6%) |
| Dec 2022 | $165.37 M(+635.1%) | $165.37 M(-9.6%) |
| Sept 2022 | - | $182.85 M(-12.1%) |
| June 2022 | - | $208.11 M(+699.7%) |
| Mar 2022 | - | $26.02 M(+15.7%) |
| Dec 2021 | $22.50 M(-64.5%) | $22.50 M(-14.0%) |
| Sept 2021 | - | $26.18 M(+3.2%) |
| June 2021 | - | $25.36 M(-40.7%) |
| Mar 2021 | - | $42.80 M(-32.5%) |
| Dec 2020 | $63.41 M(+0.2%) | - |
| Dec 2020 | - | $63.41 M(-20.6%) |
| Sept 2020 | - | $79.87 M(+99.2%) |
| June 2020 | - | $40.10 M(-14.8%) |
| Mar 2020 | - | $47.07 M(-25.6%) |
| Dec 2019 | $63.27 M(-29.3%) | - |
| Dec 2019 | - | $63.27 M(+0.1%) |
| Sept 2019 | - | $63.19 M(-9.0%) |
| June 2019 | - | $69.46 M(-10.1%) |
| Mar 2019 | - | $77.30 M(-13.7%) |
| Dec 2018 | $89.52 M(+46.0%) | $89.52 M(+171.3%) |
| Sept 2018 | - | $32.99 M(-14.5%) |
| June 2018 | - | $38.60 M(-18.4%) |
| Mar 2018 | - | $47.30 M(-22.9%) |
| Dec 2017 | $61.33 M | $61.33 M(-4.6%) |
| Sept 2017 | - | $64.28 M(+43.5%) |
| June 2017 | - | $44.80 M(-18.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | $54.82 M(-18.4%) |
| Dec 2016 | $67.17 M(-41.1%) | $67.17 M(-16.2%) |
| Sept 2016 | - | $80.17 M(-15.4%) |
| June 2016 | - | $94.73 M(-11.7%) |
| Mar 2016 | - | $107.28 M(-5.9%) |
| Dec 2015 | $114.01 M(-9.9%) | $114.01 M(-3.4%) |
| Sept 2015 | - | $117.97 M(+3.1%) |
| June 2015 | - | $114.45 M(-12.2%) |
| Mar 2015 | - | $130.33 M(+3.0%) |
| Dec 2014 | $126.51 M(+46.0%) | $126.51 M(+19.9%) |
| Sept 2014 | - | $105.51 M(+5.4%) |
| June 2014 | - | $100.13 M(-34.6%) |
| Mar 2014 | - | $153.08 M(+76.7%) |
| Dec 2013 | $86.63 M(-3.3%) | $86.63 M(+21.0%) |
| Sept 2013 | - | $71.61 M(+3.9%) |
| June 2013 | - | $68.92 M(-20.8%) |
| Mar 2013 | - | $87.02 M(-2.9%) |
| Dec 2012 | $89.61 M(+79.7%) | $89.61 M(-3.0%) |
| Sept 2012 | - | $92.42 M(+125.8%) |
| June 2012 | - | $40.93 M(+5.2%) |
| Mar 2012 | - | $38.91 M(-22.0%) |
| Dec 2011 | $49.86 M(+2004.8%) | $49.86 M(-11.5%) |
| Sept 2011 | - | $56.37 M(-10.8%) |
| June 2011 | - | $63.23 M(-12.5%) |
| Mar 2011 | - | $72.30 M(+2951.8%) |
| Dec 2010 | $2.37 M(-88.9%) | $2.37 M(-65.2%) |
| Sept 2010 | - | $6.82 M(-68.1%) |
| Dec 2009 | $21.35 M(+3.1%) | $21.35 M(+3.1%) |
| Dec 2008 | $20.70 M(-46.6%) | $20.70 M(-27.7%) |
| June 2008 | - | $28.64 M(-26.1%) |
| Dec 2007 | $38.75 M(+61.9%) | $38.75 M |
| Dec 2006 | $23.94 M | - |
FAQ
- What is Standard BioTools annual working capital?
- What is the all time high annual working capital for Standard BioTools?
- What is Standard BioTools annual working capital year-on-year change?
- What is Standard BioTools quarterly working capital?
- What is the all time high quarterly working capital for Standard BioTools?
- What is Standard BioTools quarterly working capital year-on-year change?
What is Standard BioTools annual working capital?
The current annual working capital of LAB is $48.89 M
What is the all time high annual working capital for Standard BioTools?
Standard BioTools all-time high annual working capital is $165.37 M
What is Standard BioTools annual working capital year-on-year change?
Over the past year, LAB annual working capital has changed by -$116.48 M (-70.44%)
What is Standard BioTools quarterly working capital?
The current quarterly working capital of LAB is $332.99 M
What is the all time high quarterly working capital for Standard BioTools?
Standard BioTools all-time high quarterly working capital is $426.01 M
What is Standard BioTools quarterly working capital year-on-year change?
Over the past year, LAB quarterly working capital has changed by +$214.05 M (+179.96%)